Recommendation of the President – Edarabid (edarawon)
On 26 June 2025, the President of the Agency for Health Technology Assessment and Tariff System issued recommendation No. 77/2025 on the validity of granting approval for reimbursement of the medicinal product Edarabid (edarawon) for the indication: amyotrophic lateral sclerosis